(Q69580108)
Statements
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of Cancer (English)
P Hurteloup
J P Armand
M Schneider
P Bastit
B Chevallier
C Pourny
R Keiling
C de Oliveira
M Hayat